1. Home
  2. OSRH vs VVOS Comparison

OSRH vs VVOS Comparison

Compare OSRH & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OSR Holdings Inc.

OSRH

OSR Holdings Inc.

N/A

Current Price

$0.51

Market Cap

18.4M

Sector

N/A

ML Signal

N/A

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

N/A

Current Price

$1.33

Market Cap

15.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OSRH
VVOS
Founded
N/A
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.4M
15.1M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
OSRH
VVOS
Price
$0.51
$1.33
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.25
AVG Volume (30 Days)
380.7K
87.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.07
EPS
N/A
N/A
Revenue
N/A
$15,031,000.00
Revenue This Year
N/A
$31.42
Revenue Next Year
N/A
$49.82
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.91
52 Week Low
$0.38
$1.28
52 Week High
$4.33
$7.40

Technical Indicators

Market Signals
Indicator
OSRH
VVOS
Relative Strength Index (RSI) 52.64 38.14
Support Level $0.45 N/A
Resistance Level $0.74 $1.88
Average True Range (ATR) 0.05 0.12
MACD 0.02 0.00
Stochastic Oscillator 62.57 18.53

Price Performance

Historical Comparison
OSRH
VVOS

About OSRH OSR Holdings Inc.

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: